Coronavirus Outbreak: Goa-based drug maker GAPL eyes to get licence to produce hydroxychloroquine sulfate

GAPL is a subsidiary of HLL Lifecare Limited under the administrative control of Union ministry of health and family welfare. The company has a manufacturing facility at Tuem in North Goa.

Press Trust of India April 10, 2020 16:06:32 IST
Coronavirus Outbreak: Goa-based drug maker GAPL eyes to get licence to produce hydroxychloroquine sulfate

Panaji: Goa Antibiotics Private Ltd (GAPL), a central public sector undertaking, has begun the process of procuring a licence to produce hydroxychloroquine sulfate, which has been approved by the US Food and Drug Administration (FDA) for treatment of COVID-19.

Coronavirus Outbreak Goabased drug maker GAPL eyes to get licence to produce hydroxychloroquine sulfate

Representational image. Reuters.

GAPL is a subsidiary of HLL Lifecare Limited under the administrative control of Union ministry of health and family welfare. The company has a manufacturing facility at Tuem in North Goa.

"The company has a licence to produce chloroquine sulfate (not hydroxychloroquine sulfate), but we have not produced it for the last 15 year. However, we have now decided to get licence for hydroxychloroquine sulfate considering the current demand," GAPL chief executive officer Reju Skaria said on Friday.

He said that the company has been producing various pharmaceutical products depending upon the demand.

"We have the capacity to produce two crore tablets per month. We can utilise this capacity to produce any pharmaceutical product, for which we have a licence," he said.

Skaria stated that there are difficulties in availability and transporting the Active Pharmaceutical Ingredient (API) required for the formations due to current lockdown.

Updated Date:

also read

China orders Covid lockdown in Zhengzhou after iPhone factory protests
World

China orders Covid lockdown in Zhengzhou after iPhone factory protests

Residents of Zhenghzhou's city centre cannot leave the area unless they have a negative Covid test and permission from authorities, and are advised not to leave their homes "unless necessary", the local government said.

Explained: How China's zero-COVID policy has left people in Beijing frustrated
World

Explained: How China's zero-COVID policy has left people in Beijing frustrated

Beijing's tightening restrictions come as the city is reporting its highest-ever number of daily infections. Residents are now growing tired of navigating vague, shifting restrictions and uncertainties

China: Anger grows in Urumqi over Covid lockdown after deadly fire
World

China: Anger grows in Urumqi over Covid lockdown after deadly fire

Since early August, there have been restrictions in place in the city- capital of the western Xinjiang region